The experimental research on the treatment of acute myocardial infarction by trimetazidine and bone marrow mesenchymal stem cells transplantation

Zhu Gangyan,Xu Hongxin,Tian Yihao,Ma Hongmei,Tang Shiqi,Wang Fuliang,Wu Songlin

DOI: https://doi.org/10.3969/j.issn.1671-8348.2012.11.022

2012-01-01

Abstract:Objective To investigate the effects of trimetazidine(TMZ) on the survival of mesenchymal stem cells(MSCs) in an ex-vitro model of hypoxia and subsequent activities of transplanted MSCs in rat hearts with acute myocardial infarction(AMI).Methods MSCs were cultured in serum-free medium and exposed to hypoxia for 12h with or without TMZ.The viability and apoptosis of MSCs at passage 3 were examined by transmission electron microscope.Thirty wistar rats were divided randomly into 3 groups,including AMI control group,MSCs transplantation group,and TMZ+MSCs group.MSCs were injected into peri-infarct myocardium(MSCs and TMZ+MSCs groups) thirty minutes after coronary artery ligation.The rats in TMZ+MSCs group were additionally fed TMZ from 3 days before AMI to 28 days after AMI.Cardiac structure and function were assessed by echocardiography 28 days after transplantation.The survival and differentiation of transplanted cells were detected by immunofluorescent staining.The cellular apoptosis in the peri-infarct region was detected with TUNEL assay.Blood samples were collected before the start of TMZ therapy and 24h,48h after AMI,and inflammatory cytokines(CRP,TNF-α) were measured.Results In hypoxic culture,the TMZ-treated MSCs displayed a two-fold decrease in apoptosis under serum-free medium and hypoxia environment.In vivo,cardiac infarct size was significantly smaller,cardiac function significantly improved in the MSCs and TMZ+MSCs groups than those in the control group.Combined treatment with TMZ and MSCs implantation demonstrated a further decrease in MSCs apoptosis,a further increase in MSCs viability,a further decrease in infarct size,and a further improvement in cardiac function,compared with those of MSCs group.The baseline levels of inflammatory cytokines(CRP,TNF-α) were not significantly different among the groups.However,all parameters at 24h were lower in TMZ+MSCs group than those in MSCs group.Conclusion Implantation of MSCs combined with TMZ treatment is superior to MSCs monotherapy for MSCs viability and cardiac function recovery.The inhibition of inflammatory cytokines expression may be the potential mechanism.